News

Over 6% of American adults are suffering from long COVID, survey finds 05:10. Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of ...
There’s an overall dearth of drug trials for long Covid, said Ursula Hofer, editor in chief of The Lancet Infectious Diseases. Hofer contributed to a recent editorial that describes the issue: ...
Clinical trials of a new drug aimed at tackling symptoms of long COVID, made by Axcella, show that the drug worked in helping some patients overcome their fatigue.
The phase 2 investigational new drug clinical trial tested whether a 15-day course of Paxlovid, an FDA-approved antiviral for acute COVID-19, could also help long COVID patients.
One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.
COVID-19 patients who took the diabetes drug metformin for two weeks after a diagnosis were less likely to develop long COVID-19 symptoms, according to results from a clinical trial. The trial ...
In the two years since she caught the coronavirus, 38-year-old Jessica McGovern has cycled through “well over 100 drugs, supplements, and therapies” to try to keep her long-COVID symptoms at ...
An early clinical drug trial taking aim at long COVID fatigue has fallen short of a primary objective to restore normal energy-fueling cell function but still provided encouraging evidence that ...
It’s called COVID long-haul syndrome. A South Florida doctor is overseeing a new study that’s providing hope for “long-haulers.” 7’s Kevin Ozebek was granted exclusive access to the trial.
A drug that has shown promise in HIV patients could be successful in combating symptoms for coronavirus "long haulers.” The trial is set to start this spring and doctors say if it works, it ...
For the people who can’t get rid of COVID or suffer from symptoms that linger months or even a year after getting infected, a South Florida drug trial could provide hope. The drug, called ler… ...